How it Works
Etoposide is a chemotherapy medication that is used to treat a variety of cancers, including acute myeloid leukemia (AML) and multiple myeloma. It works by inhibiting the synthesis of DNA, which is necessary for the replication and growth of cancer cells.
Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces damage to the DNA and prevents repair by topoisomerase II binding. Accumulated damage in DNA prevents cell division and leads to cell death.
How it’s Administered
Etoposide is given as an infusion into a vein (IV).
Who Should Take Etoposide
Etoposide is currently approved for:
- Multiple types of cancer such as multiple myeloma, testicular cancer, acute myeloid leukemia and small cell lung cancer
Who Shouldn’t Take Etoposide
- Patients that are allergic to Etoposide
- Pregnant women
The Most Common Side Effects of Taking Etoposide Include
- Sores or white patches in or around your mouth
- Difficulty swallowing or talking
- Dry mouth
- Bad breath
- Altered sense of taste
- Nausea
- Vomiting
- Temporary hair loss
Commonly Used in Multiple Myeloma With
- Doxorubicin
- Cyclophosphamide
- Cisplatin
- Dexamethasone
- Thalidomide
Currently Being Tested in Multiple Myeloma With
- Steroids: Dexamethasone
- Chemotherapy drugs: Cytarabine, Carmustine, Cisplatin, Adriamycin, Cyclophosphamide, Melphalan
- Immunomodulators agents: Thalidomide
- Proteasome inhibitors: Bortezomib, Carfilzomib
- Monoclonal antibody: Daratumumab
Commonly Used in AML With
- Mitoxantrone
- Cytarabine alone
- Cytarabine & Daunorubicin
Currently Being Tested in AML With
- Steroids: Dexamethasone
- Chemotherapy drugs: Cytarabine, Fludarabine, Cyclophosphamide, Mitoxantrone,
- FLT3 Inhibitors: Quizartinib, Sorafenib
- Protein kinase inhibitors: Axitinib, Crizotinib, Dasatinib, Erlotinib, Imatinib, Pazopanib, Ruxolitinib, Vandetanib, Vemurafenib
- Monoclonal antibody: Gemtuzumab Ozogamicin, Tocilizumab
- BCL-2 inhibitors: Venetoclax
- Antibiotics with antineoplastic activity: Daunorubicin, Idarubicin, Doxorubicin
Learn more about your treatments in Cure Hub
![newsletter icon](https://static.healthtree.org/icons/newsletter-icon.png)
Get the latest thought leadership on your Multiple Myeloma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.
Thanks to our HealthTree Community for Multiple Myeloma Sponsors:
![Johnson and Johnson](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FJohnson%20&%20Johnson%20Logo_64b18f59-85c9-4c20-a5ff-3842e69d8066.jpg?alt=media)
![Sanofi](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FSanofi%20updated%202023_d25a8d12-4f09-410c-9eb1-1e725b0b7c3e.jpg?alt=media)
![Pfizer](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FPfizer%20Logo%202024_50ae4587-5fdc-48e2-9a52-21651c643494.png?alt=media)
![Genentech](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/admin%2Fpublic%2Fshared%2FGenentech_Logo-700x182_e3c64168-dcf4-4540-9e9d-26500b26920a.png?alt=media)
![Regeneron](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FRegeneron_dec43aa4-fe53-4d5a-9b7f-4170101b47f9.webp?alt=media)
![Adaptive](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FAdaptive%20Logo%204.2023_e0d11d37-8b31-4c88-a0fc-4d07efc9b16b.png?alt=media)